Structural and functional studies of the human integrin $\alpha 4\beta 1$ (CD49d/CD29)

The integrin receptor $\alpha 4\beta 1$ is a cell surface heterodimer involved in a variety of highly regulated cellular interactions. The purpose of this dissertation was to identify and characterize unique structural and functional properties of the $\alpha 4\beta 1$ molecule that may be important for adhesion regulation and signal transduction. To study these properties and to establish a consensus sequence for the $\alpha 4$ subunit, cDNA encoding $\alpha 4$ was cloned and sequenced. A comparison with previously described human $\alpha 4$ sequences identified several substitutions in the $5\prime$ and $3\prime$ untranslated regions, and a nonsynonymous G to A transition in the coding region, resulting in a glutamine substitution for arginine. Further analysis of this single nucleotide substitution indicated that two variants of the $\alpha 4$ subunit exist, and when compared with three ancestrally-related species, the new form cloned in our laboratory was found to be evolutionarily conserved.^ The expression of $\alpha 4$ cDNA in transfected K562 erythroleukemia cells, and subsequent studies using flow cytofluorometric, immunochemical, and ligand binding/blocking analyses, confirmed $\alpha 4\beta 1$ as a receptor for fibronectin (FN) and vascular cell adhesion molecule-1 (VCAM-1), and provided a practical means of identifying two novel monoclonal antibody (mAb) binding epitopes on the $\alpha 4\beta 1$ complex that may play important roles in the regulation of leukocyte adhesion.^ To investigate the association of $\alpha 4\beta 1$-mediated adhesion with signals involved in the spreading of lymphocytes on FN, a quantitative method of analysis was developed using video microscopy and digital imaging. The results showed that HPB-ALL $(\alpha 4\beta 1\sp{\rm hi},\ \alpha 5\beta 1\sp-)$ cells could adhere and actively spread on human plasma FN, but not on control substrate. Many cell types which express different levels of the $\alpha 4\beta 1$ and $\alpha 5\beta 1$ FN binding integrins were examined for their ability to function in these events. Using anti-$\alpha 4$ and anti-$\alpha 5$ mAbs, it was determined that cell adhesion to FN was influenced by both $\beta 1$ integrins, while cell spreading was found to be dependent on the $\alpha 4\beta 1$ complex. In addition, inhibitors of phospholipase A$\sb2$ (PLA$\sb2$), 5-lipoxygenases, and cyclooxygenases blocked HPB-ALL cell spreading, yet had no effect on cell adhesion to FN, and the impaired spreading induced by the PLA$\sb2$ inhibitor cibacron blue was restored by the addition of exogenous arachidonic acid (AA). These results suggest that the interaction of $\alpha 4\beta 1$ with FN, the activation of PLA$\sb2,$ and the subsequent release of AA, may be involved in lymphocyte spreading. ^

cDNA cloning and expression of a novel cell surface-expressed \b heparan sulfate/heparin \b interacting \b protein (HIP) from human cell lines and functional studies of a synthetic HIP peptide

Heparan sulfate proteoglycans and their corresponding binding sites have been suggested to play an important role during the initial attachment of blastocysts to uterine epithelium and human trophoblastic cell lines to uterine epithelial cell lines. Previous studies on RL95 cells, a human uterine epithelial cell line, characterized a single class of cell surface heparin/heparan sulfate (HP/HS)-binding sites. Three major HP/HS-binding peptide fragments were isolated from RL95 cell surfaces by tryptic digestion and partial amino-terminal amino acid sequence from each peptide fragment was obtained. In the current study, using the approaches of reverse transcription-polymerase chain reaction and cDNA library screening, a novel cell surface $\rm\underline{H}$P/HS $\rm\underline{i}$nteracting $\rm\underline{p}$rotein (HIP) has been isolated from RL95 cells. The full-length cDNA of HIP encodes a protein of 259 amino acids with a calculated molecular weight of 17,754 Da and pI of 11.75. Transfection of HIP cDNA into NIH-3T3 cells demonstrated cell surface expression and a size similar to that of HIP expressed by human cells. Predicted amino acid sequence indicates that HIP lacks a membrane spanning region and has no consensus sites for glycosylation. Northern blot analysis detected a single transcript of 1.3 kb in both total RNA and poly(A$\sp+$) RNA. Examination of human cell lines and normal tissues using both Northern blot and Western blot analysis revealed that HIP is differentially expressed in a variety of human cell lines and normal tissues, but absent in some cell lines examined. HIP has about 80% homology, at the level of both mRNA and protein, to a rodent protein, designated as ribosomal protein L29. Thus, members of the L29 family may be displayed on cell surfaces where they participate in HP/HS binding events. Studies on a synthetic peptide derived from HIP demonstrate that HIP peptide binds HS/HP with high selectivity and has high affinity (Kd = 10 nM) for a subset of polysaccharides found in commercial HIP preparations. Moreover, HIP peptide also binds certain forms of cell surface, but not secreted or intracellular. HS expressed by RL95 and JAR cells. This peptide supports the attachment of several human trophoblastic cell lines and a variety of mammalian adherent cell lines in a HS-dependent fashion. Furthermore, studies on the subset of HP specifically recognized by HIP peptide indicate that this high-affinity HP (HA-HP) has a larger median MW and a greater negative charge density than bulk HP. The minimum size of oligosaccharide required to bind to HIP peptide with high affinity is a septa- or octasaccharide. HA-HP also quantitatively binds to antithrombin-III (AT-III) with high affinity, indicating that HIP peptide and AT-III may recognize the same or similar oligosaccharide structure(s). Furthermore, HIP peptide antagonizes HP action and promotes blood coagulation in both factor Xa- and thrombin-dependent assays. Finally, HA-HP recognized by HP peptide is highly enriched with anticoagulant activity relative to bulk HP. Collectively, these results demonstrate that HIP may play a role in the HP/HS-involved cell-cell and cell-matrix interactions and recognizes a motif in HP similar or identical to that recognized by AT-III and therefore, may modulate blood coagulation. ^

CHROMOSOMAL MAPPING, LINKAGE RELATIONSHIPS, AND EVOLUTIONARY STUDIES OF THE HUMAN ANONYMOUS DNA CLONE D1S1 (IN SITU HYBRIDIZATION, PRIMATES, GENE MAPPING, AUTOSOMAL DOMINANT RETINITIS PIGMENTOSA, GENE DUPLICATION)

D1S1, an anonymous human DNA clone originally called (lamda)Ch4-H3 or (lamda)H3, was the first single copy mapped to a human chromosome (1p36) by in situ hybridization. The chromosomal assignment has been confirmed in other laboratories by repeating the in situ hybridization but not by another method. In the present study, hybridization to a panel of hamster-human somatic cell hybrids revealed copies of D1S1 on both chromosomes 1 and 3. Subcloning D1S1 showed that the D1S1 clone itself is from chromosome 3, and the sequence detected by in situ hybridization is at least two copies of part of the chromosome 3 copy. This finding demonstrates the importance of verifying gene mapping with two methods and questions the accuracy of in situ hybridization mapping.^ Non-human mammals have only one copy of D1S1, and the non-human primate D1S1 map closely resembles the human chromosome 3 copy. Thus, the human chromosome 1 copies appear to be part of a very recent duplication that occurred after the divergence between humans and the other great apes.^ A moderately informative HindIII D1S1 RFLP was mapped to chromosome 3. This marker and 12 protein markers were applied to a linkage study of autosomal dominant retinitis pigmentosa (ADRP). None of the markers proved linkage, but adding the three families examined to previously published data raises the ADRP:Rh lod score to 1.92 at (THETA) = 0.30. ^

Optimized on-line enantioselective capillary electrophoretic method for kinetic and inhibition studies of drug metabolism mediated by cytochrome P450 enzymes.

Pharmacokinetic and pharmacodynamic properties of a chiral drug can significantly differ between application of the racemate and single enantiomers. During drug development, the characteristics of candidate compounds have to be assessed prior to clinical testing. Since biotransformation significantly influences drug actions in an organism, metabolism studies represent a crucial part of such tests. Hence, an optimized and economical capillary electrophoretic method for on-line studies of the enantioselective drug metabolism mediated by cytochrome P450 enzymes was developed. It comprises a diffusion-based procedure, which enables mixing of the enzyme with virtually any compound inside the nanoliter-scale capillary reactor and without the need of additional optimization of mixing conditions. For CYP3A4, ketamine as probe substrate and highly sulfated γ-cyclodextrin as chiral selector, improved separation conditions for ketamine and norketamine enantiomers compared to a previously published electrophoretically mediated microanalysis method were elucidated. The new approach was thoroughly validated for the CYP3A4-mediated N-demethylation pathway of ketamine and applied to the determination of its kinetic parameters and the inhibition characteristics in presence of ketoconazole and dexmedetomidine. The determined parameters were found to be comparable to literature data obtained with different techniques. The presented method constitutes a miniaturized and cost-effective tool, which should be suitable for the assessment of the stereoselective aspects of kinetic and inhibition studies of cytochrome P450-mediated metabolic steps within early stages of the development of a new drug.

CYTOLOGICAL, ULTRASTRUCTURAL, AND BIOCHEMICAL STUDIES OF THE STRUCTURE OF PREMATURELY CONDENSED CHROMOSOMES

The phenomenon of premature chromosome condensation, resulting from fusion between mitotic and interphase cells, includes dissolution of the interphase nuclear framework, thus allowing a direct visualization of interphase chromosomes. Light microscope morphology of prematurely condensed chromosomes (PCC) from synchronized HeLa cells supports the model of an interphase "chromosome condensation cycle". PCC are increasingly attenuated as cells progress through G(,1). A maximum degree of decondensation is observed at active sites of DNA replication during S phase, and a condensed morphology is rapidly resumed following completion of replication of a chromosome segment.^ To permit ultrastructural and biochemical studies of PCC, a procedure was developed to induce premature chromosome condensation at high frequency. This was achieved by polyethylene glycol (PEG)-mediated fusion of a dense monolayer of mitotic and interphase cells induced by centrifugation onto lectin-coated culture dishes. Using this method, PCC induction frequencies of 60-90% are routinely obtained.^ Scanning electron microscope analysis of PCC spreads revealed that the extension of PCC during progression through G(,1) is accompanied by a transition of the basic 30 nm chromatin fiber from tightly packed looping fibers to extended longitudinal fibers. Sites of active DNA replication is S-PCC were indicated to be organized a single longitudinal fibers. Following replication of a chromosome segment, a rapid reorganization from the extended longitudinal fiber to packed looping fibers occurs. The postreplication maturation process appears to include the assembly of a chromosome core consisting of multiple longitudinal fibers.^ The role of histone H1 phosphorylation in PCC formation was investigated by acidurea polyacrylamide gel electrophoresis of total histone extracted from metaphase chromosomes and PCC following high frequency fusion. This investigation failed to demonstrate an extensive phosphorylation of H1 associated with PCC formation. However, significant dephosphorylation of superphosphorylated metaphase chromosome H1 was observed, indicating that interphase H1-phosphatase activity is dominant over metaphase H1 kinase activity. These observations provide evidence against models suggesting a role for H1 superphosphorylation in triggering mitotic condensation of chromosomes. ^

Development and formative evaluation of an obesity prevention intervention for the pediatric primary care setting: Helping HAND (Healthy Activity and Nutrition Directions)

As the obesity epidemic continues to increase, the pediatric primary care office setting remains a relatively unexplored arena to offer obesity prevention interventions for children. The increased risk for adult obesity among 10 to 14 year-old children who are overweight, suggests obesity prevention programs should be introduced just before this age or early in this age period. Research is also accumulating on the importance of targeting parents along with children, since parents are in charge of the home environment for children. Therefore, the aim of this project was to develop an obesity prevention program called Helping HAND (Healthy Activity and Nutrition Directions) based on Social Cognitive Theory and authoritative parenting techniques for the pediatric primary care setting and conduct one-on-one interviews with parents as the initial formative evaluation of the intervention material for the obesity prevention intervention. A secondary aim of the project was to determine the feasibility of identifying appropriate subjects for the intervention, and conducting qualitative evaluations of the materials through recruitment through pediatric primary care settings. ^

Neutronics design and radiological aspects of HiPER facilities

En este trabajo se han cubierto diferentes asuntos del diseño neutrónico de los aspectos radiológicos de las dos instalaciones del proyecto HiPER. El proyecto HiPER es un proyecto europeo concebido en el marco del programa ESFRI (European Scientific Facilities Research Infrastructure). Está destinado al desarrollo de la energía de fusión nuclear inercial mediante el uso de láseres y el esquema iluminación directa. Consecuentemente, se trata de una instalación con fines exclusivamente civiles. Se divide en dos fases, correspondientes con dos instalaciones: HiPER Engineering y HiPER Reactor. La instalación HiPER Engineering desarrollará las tecnologías implicadas en la ignición de alta repetición de cápsulas de DT por iluminación directa. El HiPER Reactor será una planta demostradora que produzca electricidad haciendo uso de las tecnologías desarrolladas durante la fase HiPER Engineering. El HiPER Engineering se centrará en las tecnologías relevantes para las igniciones a alta repetición de cápsulas de DT usando la iluminación directa. El principal esfuerzo de desarrollo tecnológico se hará en todos los asuntos directamente relacionados con la ignición: láseres, óptica, inyector, y fabricación masiva de cápsulas entre otros. Se espera una producción de entre 5200 MJ/año y 120000 MJ/año dependiendo del éxito de la instalación. Comparado con la energía esperada en NIF, 1200 MJ/año, se trata de un reto y un paso más allá en la protección radiológica. En este trabajo se ha concebido una instalación preliminar. Se ha evaluado desde el punto de vista de la protección radiológica, siendo las personas y la óptica el objeto de protección de este estudio. Se ha establecido una zonificación durante la operación y durante el mantenimiento de la instalación. Además, se ha llevado a cabo una evaluación de la selección de materiales para la cámara de reacción desde el punto de vista de gestión de residuos radiactivos. El acero T91 se ha seleccionado por, siendo un acero comercial, presentar el mismo comportamiento que el acero de baja activación EUROFER97 al evaluarse como residuo con el nivel de irradiación de HiPER Engineering. Teniendo en cuenta los resultados obtenidos para la instalación preliminar y las modificaciones de la instalación motivadas en otros campos, se ha propuesto una instalación avanzada también en este trabajo. Un análisis más profundo de los aspectos radiológicos, así como una evaluación completa de la gestión de todos los residuos radiactivos generados en la instalación se ha llevado a cabo. La protección radiológica se ha incrementado respecto de la instalación preliminar, y todos los residuos pueden gestionarse en un plazo de 30 sin recurrir al enterramiento de residuos. El HiPER Reactor sera una planta demostradora que produzca electricidad basada en las tecnologías de ignición desarrolladas durante la fase HiPER Engineering. El esfuerzo de desarrollo tecnológico se llevará a cabo en los sistemas relacionados con la generación de electricidad en condiciones económicas: manto reproductor de tritio, ciclos de potencia, vida y mantenimiento de componentes, o sistemas de recuperación de tritio entre otros. En este trabajo la principal contribución a HiPER Reactor está relacionada con el diseño de la cámara de reacción y sus extensiones en la planta. La cámara de reacción es la isla nuclear más importante de la planta, donde la mayoría de las reacciones nucleares tienen lugar. Alberga la primera pared, el manto reproductor de tritio y la vasija de vacío. Todo el trabajo realizado aquí ha pivotado en torno al manto reproductor de tritio y sus interacciones con el resto de componentes de la planta. Tras una revisión profunda de la bibliografía de los diseños recientes de cámaras de reacción con características similares a HiPER Reactor, se ha propuesto y justificado un esquema tecnológico innovador para el manto reproductor de tritio. El material fértil selecconado es el eutéctico 15.7 at.% Litio – 84.3 at.% Plomo, LiPb, evitando el uso de berilio como multiplicador neutrónico mientras se garantiza el ajuste online de la tasa de reproducción de tritio mediante el ajuste en el enriquecimiento en 6Li. Aunque se podría haber elegido Litio purom el LiPb evita problemas relacionados con la reactividad química. El precio a pagar es un reto materializado como inventario radiactivo de Z alto en el lazo de LiPb que debe controlarse. El material estructural seleccionado es el acero de baja activación EUROFER97, que estará en contacto directo con le LiPb fluyendo a alta velocidad. En este esquema tecnológico, el LiPb asegurará la autosuficiente de tritio de la planta mientras el propio LiPb extrae del manto el calor sobre él depositado por los neutrones. Este esquema recibe el nombre de manto de Litio-Plomo auto-refrigerado (SCLL por sus siglas en inglés). Respecto de los conceptos SCLL previos, es destacable que nos e requieren componentes del SiC, puesto que no hay campos magnéticos en la cámara de reacción. Consecuentemente, el manto SCLL propuesto para HiPER presenta riesgo tecnológicos moderados, similares a otros dispositivos de fusión magnética, como el HCLL, e incluso inferiores a los del DCLL, puesto que no se require SiC. Los retos que se deben afrontar son el control del inventario de Z alto así como las tasas de corrosión derivadas de la interacción del LiPb con el EUROFE97. En este trabajo se abordan ambos aspectos, y se presentan los respectivos análisis, junto con otros aspectos neutrónicos y de activación, tales como la protección de la vasija de vacío por parte del material fértil para garantizar la resoldabilidad de por vida en la cara externa de la vasija. También se propone y se estudio un ciclo de potencia de Brayton de Helio para dos configuraciones diferentes de refrigeración del sistema primera pared-manto reproductor. Las principales conclusiones de estos estudios son: i) el inventario de Z alto puede controlarse y es comparable al que se encuentra en dispositivos de fusión similares, ii)la vasija de vacío requiere una mayor protección frente a la radiación neutrónica y iii) las tasas de corrosión son demasiado altas y la temperatura media de salida del LiPb es demasiado baja. Tiendo en cuenta estos resultados juntos con otras consideraciones relacionadas con el mantenimiento de componentes y la viabilidad constructiva, se ha propuesto una evolución de la cámara de reacción. Las evoluciones más destacables son la introducción de un reflector neutrónico de grafito, la modificación de la configuración de la óptica final, la forma y el tamaño de la cámara de vacío y una nueva subdivisión modular del manto. Se ha evaluado desde el punto de vista neutrónico, y su análisis y posterior evolución queda fuera del objeto de este trabajo. Los códigos utilizados en este trabajo son: CATIA para la generación de geometrías 3D complejas MCAM para la traducción de archivos de CATIA a formato de input de MCNP MCNP para el transporte de la radiación (neutrones y gammas) y sus respuestas asociadas ACAB para la evolución del inventario isotópico y sus respuestas asociadas MC2ACAB para acoplar MCNP y ACAB para el cómputo de dosis en parada usando la metodología R2S basada en celda. Moritz para visualizar los reultados de MCNP FLUENT para llevar a cabo cálculos de fluido-dinámica Para llevar a cabo este trabajo, han sido necesarias unas destrezas computacionales. Las más relevantes utilizadas son: generación de geometrás 3D complejas y transmisión a MCNP, diferentes tñecnica de reducción de varianza como importancia por celdas y weight windows basado en malla, metodología Rigorous-two-Steps basada en celdas para el cálculo de dosis en parada y la modificación del código ACAB para el cálculos con múltiples espectros en la misma simulación. Como resumen, la contribución de este trabajo al proyecto HiPER son dos diseños conceptuales de instalación: una para HiPER Engineering y otra para HiPER Reactor. La primera se ha estudio en profundidad desde el punto de vista de protección radiológica y gestión de residuos, mientras que la segunda se ha estudiado desde el punto de vista de operación: seguridad, comportamiento, vida y mantenimiento de componentes y eficiencia del ciclo de potencia.